← Browse by Condition
Medical Condition
refractory
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1
NCT06622694 Phase 1
Recruiting
CD7 CAR T Cells (RD13-02) in the Treatment of Relapsed/Refractory Severe Aplastic Anemia
Enrollment
15 pts
Location
China
Sponsor
Institute of Hematology & Bloo...
NCT07295704
Recruiting
Micropulse Laser in Treatment of Initial and Refractory Cases of Center-Involved Diabetic Macular Edema
Enrollment
50 pts
Location
Egypt
Sponsor
The General Authority for Teac...
NCT07167381
Recruiting
xDRIVE for Florida-based Cancer Patients
Enrollment
210 pts
Location
United States
Sponsor
First Ascent Biomedical Inc.
NCT06265545
Recruiting
Multicenter, Platform-type Clinical Study of Refractory/Recurrent Acute Myeloid Leukemia
Enrollment
120 pts
Location
China
Sponsor
Institute of Hematology & Bloo...